RE:RE:RE:RE:RE:RE:Will the recurring revenues be meaningfulThank you fib! Couldn’t have said it any better. Keep in mind, the $10 million run rate by end of year will probably be a lot higher if/ once we get that HC approval. We all are waiting for this, along with the patents. With these 2 catalysts, we should see a spike right off that, and as trials and contracts get signed... who knows what can happen with the low share count and high margins/ EBITDA. Like Aston said, no sense in quitting at the finish line, when this thing is about to blow.. or should I say GROW!
Anyways, just my 2 cents.
GLTA